pregnancy
Olopatadine (Patanol) Contraindications and Precautions
Olopatadine is classified pregnancy C. No adequate and well-controlled studies in pregnant women have been performed. The use of olopatadine in pregnant women is only justified if the benefits outweigh the possible risks to the fetus. It is known that olopatadine is excreted into breast milk. It is not known, however, if topical administration could result in sufficient systemic absorption to produce detectable concentrations in human breast milk. Caution should be exercised when olopatadine is administered to breast-feeding women.
Safe and effective use of olopatadine in children below the age of 3 years has not been established.
Olopatadine is formulated with the preservative benzalkonium chloride, which may be absorbed by soft contact lenses. Users of soft contact lenses should not administer olopatadine while wearing the lenses. Contact lenses may be inserted 10 minutes after instilling the drug. Do not use olopatadine to treat contact lens related ocular irritation.
No overall differences in safety or effectiveness have been observed between elderly and younger patients receiving olopatadine ophthalmic solution (Patanol®).
[ Last revised: 10/21/2003 5:25:00 PM ]
Related entries
Syndicate
